STAT+: Three years after the Senate grilled drug makers … nothing’s changed

WASHINGTON – Back in 2019, when the Senate Finance Committee called seven drug industry executives to testify, it seemed like proof that Washington was within striking distance of actually reining in the industry’s high prices.

“It’s past time to get beyond the excuses and make prescription drugs affordable,” Sen. Ron Wyden of Oregon, the top Democrat on the committee, told drug makers that day.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Three years after the Senate grilled drug makers … nothing’s changed »